10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure
1 Hitting around 7,000 steps a few days a week, compared to 2,000, delivers measurable protection, including: Lower all-cause mortality Lower risk of cardiovascular disease Lower cancer mortality Reduced risk of type 2 diabetes Lower rates of dementia and depression Fewer falls as you age Basically, the more you move, the better you ageand theres no too much walking point in sight
The concern is the development of thyroid cancer
Advanced Omega-3 Formula: Hiral Health's Omega 3 Fatty Acid Tablets are expertly formulated to provide optimum support for a healthy heart and reduced cholesterol levels
evaluated serum extracellular vesicles as part of a secondary analysis [90], expanding on the positive primary clinical trial outcomes [87]